tbuckley/cabot-search huggingface dataset:
Safety and Preliminary Efficacy of DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study
Authors: Guillermo Garcia-Manero, Melissa Ooi, Zhentang Lao, Harinder Gill, Yasmin Abaza, Maximilian Stahl, Tamanna Haque, Amy E. DeZern, Peter L. Greenberg, Marc Pelletier, Arti Singh, Daniel Carreon, Valerie Beaulieu, Janghee Woo
Journal: Blood (2023)
Results of a Prospective Phase II Study of Individualized 6-Mercaptopurine Dosing Based on Pharmacogenomics in Childhood Acute Lymphoblastic Leukemia in East Asia
Authors: Hyery Kim, Jung Yoon Choi, Sung Han Kang, Kyung Nam Koh, Kyung Taek Hong, Hee Young Ju, Keon Hee Yoo, Sunmin Yun, Yoomi Park, Ju Han Kim, Hyoung Jin Kang, Ho Joon Im
Journal: Blood (2023)
Updated Analysis of a Prospective, Multicenter, Observational Study on the Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma
Authors: Massimo Offidani, Carmela Zizzo, Sonia More', Irene Federici, Alessandra Bossi, Valentina Maria Manieri, Maria Teresa Petrucci, Francesca Fazio, Chiara Lisi, Francesca Farina, Marino Brunori, Francesca Fioritoni, Nicola Sgherza, Rosa De Francesco, Tommaso Caravita di Toritto, Attilio Tordi, Angela Amendola, Assunta Melaccio, Silvia Gentili, Lucia Ciuffreda, Maria Livia Del Giudice, Antonietta Pia Falcone, Alessandro Gozzetti, Simona Tomassetti, Anna Mele, Miriana Ruggieri, Agostina Siniscalchi, Rosario Bianco, Antonino Greco, Antonio Giovanni Solimando, Francesco Rotondo, Fabio Trastulli, Laura Corvatta, Erika Morsia, Serena Rupoli, Shahram Kordasti, Attilio Olivieri, Giovanni Duro
Journal: Blood (2023)
Optimization of a Universal Allogeneic CAR-T Cells Combining CRISPR and Transposon-Based Technologies for Treatment of Acute Myeloid Leukemia
Authors: Candela Ceballos Bolaños, Cristina Calviño, Ana Alfonso Pierola, Patricia Jauregui, Maria Erendira Calleja-Cervantes, Patxi San-Martin, Paula Rodríguez Márquez, Ángel Martin Mallo, Elena Iglesias, Gloria Abizanda, Saray Rodríguez Diaz, Rebeca Martínez Turrillas, Jorge Illarramendi Esteban, Ana Margarita Redondo, MC Viguria-Alegría, Carlos Panizo, Jose J. Rifon, Sara Villar, Juan J Lasarte, Susana Inogés, Ascensión López-Díaz De Cerio, Mikel Hernaez, Felipe Prosper, Juan Roberto Rodriguez-Madoz
Journal: Blood (2023)
PD-1 Expression in Lymphoma Cells Mediates Cellular Proliferation By Engaging Phosphatase SHP-1/SHP-2
Authors: Sutapa Sinha, Tammy Price-Troska, Shulan Tian, R. Leo Sakemura, Huihuang Yan, Justin Boysen, Zhiquan Wang, Xiaosheng Wu, Rong He, Min Shi, Yucai Wang, Eric W Klee, Sameer A. Parikh, Paul J Hampel, Timothy G. Call, Jose F. Leis, Tait D. Shanafelt, Stephen M Ansell, Saad S. Kenderian, Neil E. Kay, Wei Ding
Journal: Blood (2023)
Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Daratumumab (DARA) or Elotuzumab (ELO) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the CC-92480-MM-002 Trial
Authors: Paul G. Richardson, Irwindeep Sandhu, Craig C. Hofmeister, Robert Z. Orlowski, Darrell White, Angelo Belotti, Charlotte Toftmann Hansen, Noopur S. Raje, Tracy T. Chow, Zehua Zhou, Tiziana Civardi, Phillip Koo, Yue Zhu, Jessica Katz, Albert Oriol
Journal: Blood (2023)
Venetoclax Combined with Homoharringtonine,Cytarabine and Aclacinomycin (HAAV) As Induction Therapy in Newly Diagnosed Young Adult Acute Myeloid Leukemia
Authors: Zepin Zhou, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Zeyan Shi, Yunya Luo, Yaxian Tan, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Heng Li, Weihua Zhao, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood (2023)
Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Hematopoietic Stem Cell Transplantation for Large B-Cell Lymphoma
Authors: Maryam Ebadi, Xinyi Fan, Gary Schoch, Ted Gooley, Armin Rashidi, Stephen D Smith, Mazyar Shadman, Leona Holmberg, Chaitra S Ujjani, Christina Poh, Vikram Raghunathan, Naveed Ali, Phuong T Vo, Shivaprasad Manjappa, Manoj Menon, Ryan C Lynch, Carrie I Ho, Brian G Till, Ralph Ermoian, Ajay K Gopal, Yolanda D Tseng
Journal: Blood (2023)
Efficacy and Safety of Elranatamab in Black Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Subgroup Analysis of the Magnetismm Studies
Authors: Asya Varshavsky-Yanovsky, Yogesh Jethava, Don A. Stevens, Ajay K. Nooka, Patrick J. Stiff, Isabel Perez-Cruz, Eric Leip, Alexander Lesokhin
Journal: Blood (2023)
Clinical and Molecular Spectrum of Somatic Mosaic States in <i>DDX41</i> mutant Germline Predisposition Syndromes
Authors: Talha Badar, Terra L Lasho, Yael Kusne, Ludovica Marando, Abhishek A Mangaonkar, Christy M Finke, James M. Foran, Aref Al-Kali, Hassan Alkhateeb, Naseema Gangat, Rong He, David Viswanatha, Mark R. Litzow, Timothy Chlon, Alejandro Ferrer, Mrinal M. Patnaik
Journal: Blood (2023)
Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
Authors: Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Matthew Schwede, Kailee Tanaka, Matthew Alkaitis, Raymond Yin, Brian J. Sworder, Gabriel Mannis, Ravindra Majeti, Michael S. Khodadoust, David M. Kurtz, Tian Y. Zhang
Journal: Blood (2023)
Evaluation of Disparities in Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patient Treatment Patterns in a Large US Health System
Authors: Kristin J. Moore, Nicole M. Engel-Nitz, Peter McMahon, Jason Beal, Teraneh Z. Jhaveri, Mellissa Williamson, Katherine Andrade, Christina Landis, Islam Sadek, Cosmina Hogea
Journal: Blood (2023)
Results of a Phase 1 Trial Testing the Novel Combination Therapy of Venetoclax and Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia Patients
Authors: Uma M. Borate, Yazan F. Madanat, Cristina Tognon, Shikha Mishra, Andy Kaempf, Prapti A. Patel, Stephen E. Kurtz, Kara Johnson, Sumithira Vasu, Sharyn D. Baker, Bridget A Robinson, Tania Q Vu, Christopher A. Eide, Jessica Minnier, Yiqing Zhang, Peter Clement, Sammantha Avaylon, Thomas Jacob, Rachel Cook, Arpita Gandhi, Jessica T. Leonard, Brandon Hayes-Lattin, Laura F. Newell, Richard T Maziarz, Elie Traer, Ronan T. Swords, Jeffrey W Tyner, Brian J. Druker, Jennifer N. Saultz
Journal: Blood (2023)
Cellular Dynamics Following CAR T Cell Therapy Are Associated with Response, Resistance and Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma
Authors: Luise Fischer, Patrick Born, Ronald Weiss, Nora Grieb, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Christina Kloetzer, Simone Heyn, Ronny Baber, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Koehl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Journal: Blood (2023)
IRF2 Regulates <i>De Novo</i> Active Chromatin Regions and Participates in the Development and Pathogenesis of Multiple Myeloma
Authors: Nahia Gomez-Echarte, Arantxa Carrasco-León, Alba Maiques-Diaz, Estibaliz Miranda, Leire Garate, Patxi San-Martin, Stella Charalampopoulou, Luis Vitores Valcárcel, Inaki Martin-Subero, Edurne San josé-Eneriz, Xabier Agirre, Felipe Prosper
Journal: Blood (2023)
A Phase I/II Single Arm Study of Belantamab Mafodotin, Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Planned Interim Analysis of Safety and Efficacy. Amarc 19-02 Belacard Study
Authors: Masa Lasica, Andrew Spencer, Noemi Horvath, Wojt Janowski, Douglas Coghlan, Craig Wallington-Gates, Philip Campbell, Hock Choong Lai, Georgia McCaughan, Nicholas Weber, Anish Puliyayil, Philip Wong, Deng Yachao, Khoa Le, John Reynolds, Hang Quach
Journal: Blood (2023)
Despite High Rates of Remission, Treatment of IDH-Mutant AML with Hypomethylating Agents and Venetoclax Is Associated with Frequent Treatment Delays, Modifications, and Transfusions
Authors: Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, Gaurav Gupta, Prabhakar Borge, Ellin Berman, Mark Blaine Geyer, Aaron D. Goldberg, Tamanna Haque, Raajit K. Rampal, Jae H. Park, Lindsey E. Roeker, Martin S. Tallman, Eytan M. Stein
Journal: Blood (2023)
Machine Learning-Based Time-Series Clustering Identifies Archetypal Trajectories of Hematotoxicity after CAR T-Cell Therapy
Authors: Emily C Liang, Aya Albittar, Andrew J Portuguese, Jennifer J. Huang, Qian Wu, Joseph De Los Reyes, Nikki Pin, Aiko Torkelson, Delaney Kirchmeier, Abigail Chutnik, Barbara Pender, Joshua A. Hill, Rahul Banerjee, Andrew J. Cowan, Damian J Green, Ajay K Gopal, Christina Poh, Mazyar Shadman, Alexandre V Hirayama, Brian G Till, Erik L Kimble, Lorenzo Iovino, Aude G Chapuis, Folashade Otegbeye, Ryan D Cassaday, Filippo Milano, David G Maloney, Jordan Gauthier
Journal: Blood (2023)
Automatic Generation of Alloreactivity-Reduced Donor Lymphocytes and Hematopoietic Stem Cells from the Same Mobilized Apheresis Product
Authors: Eliza Wiercinska, Patricia Quade-Lyssy, Christiane Hümmer, Josephine Beifuß, Karima Akarach, Carolin Poppe, Valeriya Olevska, Heike Lahnor, Julia Dzionek, Andreas Bosio, Eleni Papanikolaou, Halvard Bonig
Journal: Blood (2023)
Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission
Authors: Yoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, Tomotaka Sobue, Satoshi Yamasaki, Tadakazu Kondo, Shohei Mizuno, Kaito Harada, Noriko Doki, Masatsugu Tanaka, Ayumu Ito, Tetsuya Nishida, Hiroyuki Ohigashi, Naoyuki Uchida, Ken-ichi Matsuoka, Yoshinobu Kanda, Makoto Onizuka, Toshiro Kawakita, Nobuhiro Hiramoto, Masashi Sawa, Kentaro Fukushima, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masamitsu Yanada
Journal: Blood (2023)
Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B-Cell Maturation Antigen (BCMA) × CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study
Authors: Noffar Bar, Maria Victoria Mateos, Paz Ribas, Markus Hansson, Laura Paris, Craig C. Hofmeister, Paula Rodriguez Otero, Maria Aranzazu Bermúdez, Thomas Martin, Armando Santoro, Andrew J. Yee, Maria Creignou, Cristina Encinas Rodriguez, Claudio Cerchione, Javier De La Rubia, Albert Oriol, Heidi Waibel, Britta Besemer, Ethan Thompson, Brian Kiesel, Jinjie Chen, Alexander Chung, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano Costa
Journal: Blood (2023)
Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome (CRS) with Teclistamab Administration
Authors: Ellen Marin, Sara Scott, Kathryn Maples, Nisha S. Joseph, Craig C. Hofmeister, Vikas A. Gupta, Madhav V. Dhodapkar, Jonathan L. Kaufman, Sagar Lonial, Ajay K. Nooka
Journal: Blood (2023)
Herpesvirus Entry Mediator As a Novel Therapeutic Target in Multiple Myeloma
Authors: Milad Moloudizargari, Ada Alice Dona, Miso Park, Theophilus Tandoh, Mariam Murtadha, Enrico Caserta, Alexander Pozhitkov, Yinghui Zhu, Ottavio Napolitano, James Sanchez, Lokesh Nigam, Amanda Duplan, Arnab Chowdhury, Lucy Y. Ghoda, Jonathan Keats, Scott R. Goldsmith, Michael Rosenzweig, Amrita Krishnan, John C. Williams, Flavia Pichiorri
Journal: Blood (2023)
Risk Factors and Prognostic Model for II-IV aGVHD in Patients with Engraftment Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation
Authors: Song Wang, Yan Zhu, Xiaolu Zhu, Haixia Fu, Yun He, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Chenhua Yan, Yuhong Chen, Xiangyu Zhao, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang
Journal: Blood (2023)
Belantamab Mafodotin in Combination with Lenalidomide Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Analysis of DREAMM-6 Trial Arm-a
Authors: Rakesh Popat, Bradley Augustson, Mercedes Gironella, Cindy Lee, Paul Cannell, Nashita Patel, Ravi Kasinathan, Rachel Rogers, Amy Curry, Fernando Carreno, Sumita Roy-Ghanta, Joanna Opalinska, Hang Quach
Journal: Blood (2023)
DNMT3A Mutants Are Enriched in NPMc+ AML and Associated with Adverse Outcome in Childhood AML
Authors: Rhonda E Ries, Xiaotu Ma, Claudia Tregnago, Todd A. Alonzo, Jim Wang, Tiffany Hylkema, Benjamin J Huang, Alireza Torabi, Jack H Peplinski, Logan K Wallace, Richard Aplenc, Alan S Gamis, Katherine Tarlock, Franco Locatelli, Martina Pigazzi, Soheil Meshinchi
Journal: Blood (2023)
Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) Patients with Prior cBTKi: Safety and Efficacy Including High-Risk Subgroup Analyses from the Phase 1/2 BRUIN Study
Authors: Jonathon B. Cohen, Nirav N. Shah, Wojciech Jurczak, Pier Luigi Zinzani, Chan Y. Cheah, Toby A. Eyre, Chaitra S Ujjani, Youngil Koh, Won Seog Kim, Sunita D. Nasta, Ian W. Flinn, Benoit Tessoulin, Shuo Ma, Alvaro J. Alencar, David Lewis, Jennifer A. Woyach, Kami J. Maddocks, Krish Patel, Yucai Wang, Joanna M. Rhodes, Constantine S. Tam, John F. Seymour, Hirokazu Nagai, Julie M. Vose, Bita Fakhri, Marc S. Hoffmann, Francisco J. Hernandez-Ilizaliturri, Andrew D. Zelenetz, Anita Kumar, Talha Munir, Donald E. Tsai, Minna Balbas, Bin Liu, Amy S. Ruppert, Bastien Nguyen, Lindsey E. Roeker, Michael L. Wang
Journal: Blood (2023)
Erythroid Progenitor Cells in the Murine Bone Marrow: Parallels with Human Counterparts and Response to Acute Anemia
Authors: Kathleen E. McGrath, Paul D. Kingsley, Eli T. Rust, Vincent P Schulz, Anne Koniski, Taylor L. Schofield, Leah A. Vit, Mohandas Narla, Lionel Blanc, Laurie A. Steiner, Patrick G Gallagher, James Palis
Journal: Blood (2023)
Unraveling the Role of PIEZO1 in Stressed Erythropoiesis: Implications for Dyserythropoiesis and Potential Therapeutic Targets in Dehydrated Hereditary Stomatocytosis
Authors: Barbara Eleni Rosato, Vanessa D'Onofrio, Antonella Nostroso, Roberta Marra, Federica Maria Esposito, Maddalena Raia, Giuseppe D'Alterio, Mario Capasso, Lucia De Franceschi, Achille Iolascon, Roberta Russo, Immacolata Andolfo
Journal: Blood (2023)
Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit (CLPP) As a Novel Mediator of, and Target in High Risk Multiple Myeloma
Authors: Li Qin, Luz Yurany Moreno Rueda, Iqbal Mahmud, Isere Kuiatse, Wei Tan, Hans C. Lee, Krina K. Patel, David E. Symer, Elisabet E. Manasanch, Robert Z. Orlowski
Journal: Blood (2023)
Effective and Safe Molecular-Pharmacodynamic Once Weekly Dosing of Decitabine and Venetoclax Is a Highly Effective and Well-Tolerated Induction Therapy for AML: Interim Results of a Phase 2 Trial
Authors: Mendel Goldfinger, Abigail Epstein, Ioannis Mantzaris, Aditi Shastri, Kira Gritsman, Noah Kornblum, Alejandro Sica, Nishi Shah, Dennis L Cooper, Swati Goel, David Levitz, Lauren Shapiro, Kith Pradhan, Annemarie Munoz, Monica Comas, Karen Fehn, Aradhika Dhawan, Joel Victor, Yogen Saunthararajah, Amit Verma, Marina Y. Konopleva, Eric J Feldman
Journal: Blood (2023)
TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, Is a Promising Anti-Myeloma Agent Regardless of Types of Cytogenetic/Genetic Abnormality
Authors: Haruya Okamoto, Shinsuke Mizutani, Taku Tsukamoto, Yoko Katsuragawa-Taminishi, Reiko Isa, Kentaro Mizuhara, Ayako Muramatsu, Yuka Kawaji-Kanayama, Takahiro Fujino, Yuji Shimura, Junya Kuroda
Journal: Blood (2023)
The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally
Authors: Rawan Atallah, Yara Shatnawi, Aytaj Mammadzadeh, Shahrukh K Hashmi, Shabeeha K Rana, Muhammad Umair Mushtaq, Benlazar Mohamed, Nihar Desai, Thiago Xavier Carneiro, Rakesh Popat, Joseph P McGuirk, Shebli Atrash, Zahra Mahmoudjafari, Al-Ola Abdallah, Nausheen Ahmed
Journal: Blood (2023)
CNOT4 Knockout Induces Proteasome Inhibitor Resistance in Multiple Myeloma Cells
Authors: Yoshihito Horisawa, Kotaro Shirakawa, Suguru Takeuchi, Ryosuke Nomura, Yusuke Tashiro, Stanford Emani, Jelagat Caroline, Yasuhiro Kazuma, Kosuke Yusa, Akifumi Takaori-Kondo
Journal: Blood (2023)
Development of the Treatment Preference in Myelodysplasia Questionnaire (TPMQ) for Clinicians (mTPMQ), Carers (cTPMQ), and Patients (pTPMQ)
Authors: Anoop K Enjeti, Chun Yew Fong, Francesco Castaldi, Taliesha Paine, Donna Collett, Robert Morlock
Journal: Blood (2023)
<i>Overall Survival Outcomes in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients with High-Risk Molecular-Cytogenetic Features Treated with 1L Ibrutinib: A Comparative Effectiveness Study Using the Flatiron Health Data</i>
Authors: John N. Allan, Tao Ran, Zhijie Ding, Jinghua He, Alex Bokun, Zaina P Qureshi, Susan M. O'Brien
Journal: Blood (2023)
Long-Term Follow up for SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
Authors: Anjali S. Advani, Anna B Moseley, Kristen M. O'Dwyer, Brent L. Wood, Jae H. Park, Matthew J. Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L. Atallah, Aaron T. Gerds, Susan M. O'Brien, Jane L. Liesveld, Megan Othus, Mark R. Litzow, Richard M Stone, Elad Sharon, Cecilia C.S. Yeung, Jerald P. Radich, Harry P. Erba
Journal: Blood (2023)
Different Mutations in <i>SF3B1</i> Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms
Authors: Iva Trsová, Andrea Hrustincova, Monika Belickova, Monika Kaisrlikova, Zuzana Lenertová, David Kundrat, Zdenek Krejcik, Jitka Vesela, Jaroslav Cermak, Anna Jonasova, Michaela Dostalova Merkerova
Journal: Blood (2023)
Comparative Effectiveness of Reinduction Approaches for Pediatric Relapsed Acute Myeloid Leukemia
Authors: Caitlin W. Elgarten, Regina M. Myers, Alix E. Seif, Yimei Li, Daniel J. Zheng, Naomi J Winick, Elaine Morgan, Rajen Mody, Arunkumar Modi, Tamara P. Miller, Kelly Maloney, Mallorie M. Heneghan, M. Monica Gramatges, Brian T. Fisher, Kelly D. Getz, Richard Aplenc
Journal: Blood (2023)
SETDB1 Suppresses Interferon Responses and NK Cell-Mediated Immunosurveillance Specifically in Monocytic AML
Authors: Yu-Hsuan Chang, Keita Yamamoto, Takeshi Fujino, Teh-Wei Wang, Emi Sugimoto, Wenyu Zhang, Tomohiro Yabushita, E. Christine Pietsch, Barbara A. Weir, Ramona Crescenzo, Glenn S. Cowley, Ricardo M. Attar, Ulrike Philippar, Yutaka Enomoto, Yoichi Imai, Toshio Kitamura, Susumu Goyama
Journal: Blood (2023)
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
Authors: Eric Deconinck, Berengere Gruson, Sabeha Biichle, Anne Roggy, Florian Renosi, Thomas Fournet, Maxime Desmarets, Gregory Tio, Tony Marchand, Mikael Roussel, Thibaut Leguay, Jean-Philippe Vial, Francoise Huguet, Francois Vergez, Emilie Chalayer, Khaoula Mahfoudi, Fressia Honeyman, Sebastien Maury, Nicolas Freynet, Caroline Bonmati, Veronique Latger-Cannard, Eve Gehlkopf, Caroline Bret, Damien Roos Weil, Magali Le Garff-Tavernier, Sophie Rigaudeau, Gandhi Laurent Damaj, Edouard Cornet, Remy Gressin, Marie-Christine Jacob, Delphine Martineau, Aguirre Mimoun, Alice Garnier, Marion Eveillard, Alban Villate, Emmanuelle Rault, Fanny Delettre, Francine Garnache Ottou
Journal: Blood (2023)
Real-World Analysis of Teclistamab in 115 RRMM Patients from Germany
Authors: Christine Riedhammer, Florian Bassermann, Britta Besemer, Moritz Bewarder, Franziska Brunner, Alexander Carpinteiro, Hermann Einsele, Josefine Faltin, Jan Frenking, Deniz Gezer, Sarah Goldman-Mazur, Mathias Hanel, Marion Hoegner, K. Martin Kortüm, Jan Krönke, Miriam Kull, Theo Leitner, Christoph Mann, Rabea Mecklenbrauck, Maximilian Merz, Anke Morgner, Axel Nogai, Marc S. Raab, Raphael Teipel, Ralph Wäsch, Leo Rasche
Journal: Blood (2023)
Efficacy and Safety of Glofitamab in Patients with R/R DLBCL in Real Life Setting - a Retrospective Study
Authors: Ronit Gurion, Dmitri Guz, Meirav Kedmi, Chava Perry, Irit Avivi Mazza, Netanel A. Horowitz, Uri Abadi, Anat Gafter-Gvili, Pia Raanani, Neta Goldschmidt, Boaz Nachmias, Shlomzion Aumann
Journal: Blood (2023)
Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial
Authors: Adriano Venditti, Alfonso Piciocchi, Stefano Soddu, Marco Frigeni, Raffaele Palmieri, Erika Borlenghi, Nicola Fracchiolla, Maria Paola Martelli, Ernesta Audisio, Giacomo Gianfaldoni, Calogero Vetro, Nicola di Rienzo, Daniela Esposito, Ambra Di Veroli, Carmine Selleri, Federica Gigli, Antonio Curti, Antonino Mulè, Catello Califano, Sara Bigliardi, Massimo Breccia, Claudio Fozza, Monica Bocchia, Albana Lico, Federico Simonetti, Elisabetta Pierdomenico, Francesco Buccisano, Maria Ilaria Del Principe, Luca Maurillo, Paola Fazi, Marco Vignetti, Felicetto Ferrara, Roberto Cairoli, Giuseppe Rossi, Alessandro Rambaldi
Journal: Blood (2023)
Instructive Interaction between Myelodysplastic Hematopoiesis and the Bone Marrow Microenvironment at Single Cell Level
Authors: Johann-Christoph Jann, Nanni Schmitt, Alexander Streuer, Qingyu Xu, Vladimir Riabov, Nadine Weimer, Verena Nowak, Julia Oblaender, Iris Palme, Melda Göl, Marie Demmerle, Felicitas Rapp, Fabian Siegel, Laurenz Steiner, Angelika Duda, Verena Haselmann, Ali Darwich, Ahmed Jawhar, Mohamad Jawhar, Georgia Metzgeroth, Wolf-Karsten Hofmann, Daniel Nowak
Journal: Blood (2023)
Abatacept Enhances Natural Killer Cell Cytotoxicity Following Haploidentical HCT: A Novel Platform to Dissociate GVL from Gvhd
Authors: Sarita Rani Jaiswal, Mahak Agarwal, Prakash Baligar, Gitali Bhagawati, Subhrajit Biswas, Bhudev C Das, Bipin N. Savani, Suparno Chakrabarti
Journal: Blood (2023)
Composition and Dynamic Evolution of the Bone Marrow Microenvironment in AL Amyloidosis during Daratumumab Based Therapy
Authors: Raphael E Szalat, Srikanth Talluri, Charlotte M Royer, Sherry Wong, Gareth Morgan, Vaishali Sanchorawala, Mehmet K. Samur, Nikhil C Munshi
Journal: Blood (2023)
Unravelling the Mechanism behind Ineffective Erythropoiesis in Sickle Cell Disease: The Role of GATA-1
Authors: Sara El Hoss, Panicos Shangaris, John Brewin, Maria Eleni Psychogyiou, Cecilia Ng, Kypros Herodotos Nicolaides, Nicola Conran, David C Rees, John Strouboulis
Journal: Blood (2023)
A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma
Authors: Razan Mohty, Whiting Junmin, Aditi Saha, Jongphil Kim, Taiga Nishihori, Gabriel De Avila, Salvatore Corallo, Marian Dam, Jessica Marin, Hien Liu, Sepideh Mokhtari, Michael D. Jain, Fabiana Perna, Brandon Blue, Ariel F. Grajales-Cruz, Omar Castaneda, Kenneth Shain, Rachid Baz, Ciara Louise L. Freeman, Melissa Alsina, Frederick L. Locke, Doris K. Hansen, Aleksandr Lazaryan
Journal: Blood (2023)
Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 &amp;lt;75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study
Authors: Domenico Russo, Nicola Polverelli, Stella Santarone, Francesco Onida, Luca Castagna, Stefania Bramanti, A. M. Carella, Roberto Sorasio, Attilio Olivieri, Germana Beltrami, Antonio Curti, Calogero Vetro, Valentina Mancini, Elisabetta Terruzzi, Massimo Bernardi, Piero Galieni, Pellegrino Musto, Raffaella Cerretti, Luisa Giaccone, Cristina Skert, Erika Borlenghi, Mirko Farina, Alessandro Leoni, Vera Radici, Simona Bernardi, Marika Vezzoli, Stefano Calza, Angela Gheorghiu, Michele Malagola, Massimo Martino, Fabio Ciceri
Journal: Blood (2023)
Dynamic Single-Cell Profiling Reveals Novel Immune Regulatory Mechanism of ITK Inhibitor Soquelitinib in Refractory T Cell Lymphoma
Authors: Ning Ding, Yan Xie, Yong Guo, Kecheng Li, Tingting DU, Zhenjun Li, Yuejiao Li, Jiaowu Cao, Dingyao Hu, Lih-Yun Hsu, Richard Miller, Jun Zhu, Yuqin Song
Journal: Blood (2023)
Inequities in Autologous Stem Cell Transplantation, Chimeric Antigen Receptor T-Cell Therapy and Clinical Trial Participation in Patients Receiving Second-Line and Later Multiple Myeloma Treatment
Authors: Amy Pierre, Gregory S Calip, Gene Ho, Majd T Ghanim, Yichen Lu, Cleo A Ryals, Jenny S Guadamuz
Journal: Blood (2023)